BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25626370)

  • 1. Identification of tyrosine 71 as a critical residue for the cytotoxic activity of Clostridium perfringens epsilon toxin towards MDCK cells.
    Jiang Z; Chang J; Wang F; Yu L
    J Microbiol; 2015 Feb; 53(2):141-6. PubMed ID: 25626370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium perfringens epsilon toxin H149A mutant as a platform for receptor binding studies.
    Bokori-Brown M; Kokkinidou MC; Savva CG; Fernandes da Costa S; Naylor CE; Cole AR; Moss DS; Basak AK; Titball RW
    Protein Sci; 2013 May; 22(5):650-9. PubMed ID: 23504825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid residue Y196E substitution and C-terminal peptide synergistically alleviate the toxicity of Clostridium perfringens epsilon toxin.
    Yao W; Kang L; Gao S; Zhuang X; Zhang T; Yang H; Ji B; Xin W; Wang J
    Toxicon; 2015 Jun; 100():46-52. PubMed ID: 25912943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between in vitro cytotoxicity and in vivo lethal activity in mice of epsilon toxin mutants from Clostridium perfringens.
    Dorca-Arévalo J; Pauillac S; Díaz-Hidalgo L; Martín-Satué M; Popoff MR; Blasi J
    PLoS One; 2014; 9(7):e102417. PubMed ID: 25013927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etx-Y71A as a non-toxic mutant of Clostridium perfringens epsilon toxin induces protective immunity in mice and sheep.
    Jiang Z; Chang J; Wang F; Qi Y; Li Y; Yu D; Yu L
    Vaccine; 2020 Sep; 38(42):6553-6561. PubMed ID: 32788135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of
    Marshall S; McGill B; Morcrette H; Winlove CP; Chimerel C; Petrov PG; Bokori-Brown M
    Toxins (Basel); 2022 Nov; 14(11):. PubMed ID: 36356007
    [No Abstract]   [Full Text] [Related]  

  • 7. Epsilon toxin from Clostridium perfringens induces cytotoxicity in FRT thyroid epithelial cells.
    Dorca-Arévalo J; Blanch M; Pradas M; Blasi J
    Anaerobe; 2018 Oct; 53():43-49. PubMed ID: 29895394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F199E substitution reduced toxicity of Clostridium perfringens epsilon toxin by depriving the receptor binding capability.
    Kang J; Gao J; Yao W; Kang L; Gao S; Yang H; Ji B; Li P; Liu J; Yao J; Xin W; Zhao B; Wang J
    Hum Vaccin Immunother; 2017 Jul; 13(7):1598-1608. PubMed ID: 28304231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridium Perfringens Epsilon Toxin Binds to Membrane Lipids and Its Cytotoxic Action Depends on Sulfatide.
    Gil C; Dorca-Arévalo J; Blasi J
    PLoS One; 2015; 10(10):e0140321. PubMed ID: 26452234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central residues of the amphipathic β-hairpin loop control the properties of Clostridium perfringens epsilon-toxin channel.
    Knapp O; Maier E; Piselli C; Benz R; Hoxha C; Popoff MR
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183364. PubMed ID: 32450142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins as Potential Preventative Treatment of ETX and Multiple Pore-Forming Toxin-Induced Diseases.
    Huang J; Zhao B; Liu T; Kang L; Li J; Guo Z; Chen M; Gao S; Wang J; Li Y; Wang J; Xin W
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular vacuolation and mitochondrial-associated factors induced by Clostridium perfringens epsilon toxin detected using acoustic flow cytometry.
    Ferrarezi MC; Curci VC; Cardoso TC
    Anaerobe; 2013 Dec; 24():55-9. PubMed ID: 24076036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of Clostridium perfringens epsilon-toxin with biological and model membranes: A putative protein receptor in cells.
    Manni MM; Sot J; Goñi FM
    Biochim Biophys Acta; 2015 Mar; 1848(3):797-804. PubMed ID: 25485476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the channel-forming domain of Clostridium perfringens Epsilon-toxin (ETX).
    Knapp O; Maier E; Benz R; Geny B; Popoff MR
    Biochim Biophys Acta; 2009 Dec; 1788(12):2584-93. PubMed ID: 19835840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known.
    Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC
    Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung endothelial cells are sensitive to epsilon toxin from Clostridium perfringens.
    Dorca-Arévalo J; Dorca E; Torrejón-Escribano B; Blanch M; Martín-Satué M; Blasi J
    Vet Res; 2020 Feb; 51(1):27. PubMed ID: 32093740
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Kumar S; Behera SK; Gururaj K; Chaurasia A; Murmu S; Prabha R; Angadi UB; Pawaiya RS; Rai A
    J Biomol Struct Dyn; 2024 Mar; 42(5):2257-2269. PubMed ID: 37129165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium perfringens epsilon toxin is cytotoxic for human renal tubular epithelial cells.
    Fernandez Miyakawa ME; Zabal O; Silberstein C
    Hum Exp Toxicol; 2011 Apr; 30(4):275-82. PubMed ID: 20488848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CodY is a global regulator of virulence-associated properties for Clostridium perfringens type D strain CN3718.
    Li J; Ma M; Sarker MR; McClane BA
    mBio; 2013 Oct; 4(5):e00770-13. PubMed ID: 24105766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a prepore stage in the action of Clostridium perfringens epsilon toxin.
    Robertson SL; Li J; Uzal FA; McClane BA
    PLoS One; 2011; 6(7):e22053. PubMed ID: 21814565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.